NCT03866473 A Pilot Study Evaluating Photobiomodulation Therapy for Diabetic Macular Edema Status COMPLETED Phase NA
NCT03835884 A Study Assessing AR-13503 Implant in Subjects With nAMD or DME Status COMPLETED Phase PHASE1
NCT03832179 Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification Status COMPLETED Phase PHASE4
NCT03790852 Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO Status TERMINATED Phase PHASE1
NCT03784443 Combined Ranibizumab and Iluvien for Diabetic Macular Oedema Status WITHDRAWN Phase PHASE2/PHASE3
NCT03783832 Follow up of Diabetic Macular Edema Treated by Aflibercept (Eylea®) With OCT-Angiography Status UNKNOWN Phase N/A
NCT03780361 Changes in Inflammatory Biomarkers Including Soluble CD14 and Hyperreflective Foci in DME Patients Treated With Aflibercept (FORESIGHT) Status COMPLETED Phase PHASE4
NCT03762226 Influence of Systemic Parameters in Diabetic Macular Edema - LIPSIA Study Status UNKNOWN Phase N/A
NCT03759860 Laser (Selective Retina Therapy) and Drug Combined Intervention in Clinically Significant Diabetic Macular Edema Status UNKNOWN Phase PHASE4
NCT03694145 Predicting Diabetic Retinopathy From Risk Factor Data and Digital Retinal Images Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03690947 Combination of Intravitreal Ranibizumab With or Without Micropulse Laser for the Treatment of DME Status COMPLETED Phase PHASE4
NCT03690050 A Comparison of Standard Laser With Micropulse Laser for the Treatment of Diabetic Macular Oedema. Status COMPLETED Phase NA
NCT03666923 A Study to Evaluate the Safety of THR-687 in Subjects With Diabetic Macular Edema (DME) Status COMPLETED Phase PHASE1
NCT03641144 Navigation Laser Versus Traditional Laser Photocoagulation for Mild Diabetic Macular Edema Status UNKNOWN Phase NA
NCT03629210 Combination OZURDEX® & EyLea® vs. OZURDEX® Monotherapy in IncompLete-Responders wIth Diabetic Macular Edema Status WITHDRAWN Phase PHASE2
NCT03622593 A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema Status COMPLETED Phase PHASE3
NCT03622580 A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE) Status COMPLETED Phase PHASE3
NCT03610646 Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema (DME) Status COMPLETED Phase PHASE3
NCT03608839 Effect of Dexamethasone on Reduction of Macular Thickness in Diabetic Patients, a Randomized Clinical Trial Status COMPLETED Phase PHASE2